Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2014-02-12 08:29:39

Vireo's latest marketing efforts emphasize its commitment to educating consumers who are seeking an alternative to Ibuprofen and NSAIDs MADISON, Tenn., Feb. 12, 2014 /PRNewswire/ -- Vireo Systems has recently completed a major packaging and design initiative for its flagship product, AminoActiv ® (http://aminoactiv.com) the #1 alternative to Ibuprofen and NSAIDs. New product labeling and packaging formats are intended to raise AminoActiv's visibility to consumers searching for...

2014-02-11 16:26:04

WHIPPANY, N.J., Feb. 11, 2014 /PRNewswire/ -- Bayer HealthCare today issued the following press statement from Dr. Irene Laurora, Vice President, US Medical Affairs, following a joint meeting of the Arthritis Advisory Committee (AAC) and Drug Safety Committee and Risk Management Advisory Committee (DSaRM) on February 10-11, 2014. The joint Advisory Committee panel reviewed the data and analyses published since the last non-steroidal anti-inflammatory drug (NSAID) panel review in 2005...

2014-02-11 16:22:23

DUBLIN, February 11, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/v8t3kj/salicylic_acid) has announced the addition of the "Concise Analysis of the International Salicylic Acid Market - Forecast to 2019" [http://www.researchandmarkets.com/research/v8t3kj/salicylic_acid ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Salicylic acid is a beta hydroxyl acid, found naturally in...

2014-02-10 08:26:43

MISSISSAUGA, ON, Feb. 10, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced the U.S. commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%) by its U.S. commercial licensee Mallinckrodt (NYSE:MNK). PENNSAID 2% is the first twice per day topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the United States for the...

2014-02-03 23:02:55

Transparency Market Research Report Added "Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" to its database. Browse Full Report: http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html. Albany, New York (PRWEB) February 03, 2014 According to a new market report published by Transparency Market Research "Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal...

2014-01-24 08:23:33

NEW YORK, January 24, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018," the global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6...

2014-01-20 08:23:11

MIAMI, Jan. 20, 2014 /PRNewswire/ -- Many people dealing with recurring acne have avoided salicylic acid peels due to the fear of pain or the belief that chemical peels require a complicated daily regimen. Aveya Beauty (www.aveyabeauty.com) is eager to inform consumers that its Salicylic Acid Peel 20% Gel Serum, when used as directed, is not only safe and pain-free, but also highly effective. Plus, treatment with salicylic acid doesn't demand a huge time investment. Salicylic acid...

2014-01-17 08:22:56

- Mallinckrodt to Launch PENNSAID 2% in the U.S. in Q1 2014 - MISSISSAUGA, ON, Jan. 17, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology today announced that the U.S. Food and Drug Administration (FDA) has approved Mallinckrodt's New Drug Application for PENNSAID(®) (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a follow-on product to...

2014-01-16 20:22:22

F.A.S.T. Pain Relief is a new single-dose OTC liquid shot that recently launched in Seattle, WA SEATTLE, Jan. 16, 2014 /PRNewswire/ -- Consumers concerned with recent FDA warnings about risky Acetaminophen doses may be reviewing their options, and First Aid Shot Therapy® (F.A.S.T.) Liquid Pain Relief should be on their radar. This new product contains choline salicylate, which can get into the bloodstream up to five times faster than aspirin*[i], helping deliver relief from pain...

2014-01-10 23:03:17

A daily low-dose aspirin can help stave off heart attacks and certain clot-caused strokes. But fewer than half of the people who could benefit from this drug take it, while many others take it when they shouldn't. Boston, MA (PRWEB) January 10, 2014 Aspirin is often hailed as a wonder drug, thanks to its ability to help stave off heart attacks and clot-caused strokes. But fewer than half of people who could benefit from a daily low-dose aspirin take it, while many others take it when...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related